NASDAQ:TNDM - Tandem Diabetes Care Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$28.45 -1.59 (-5.29 %)
(As of 11/20/2018 04:00 PM ET)
Previous Close$30.04
Today's Range$26.40 - $30.49
52-Week Range$2.14 - $52.55
Volume2.07 million shs
Average Volume2.42 million shs
Market Capitalization$1.92 billion
P/E Ratio-2.21
Dividend YieldN/A
Beta0.53

Analyst Ratings

Tandem Diabetes Care (NASDAQ:TNDM) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
12 Wall Street analysts have issued ratings and price targets for Tandem Diabetes Care in the last 12 months. Their average twelve-month price target is $44.6250, suggesting that the stock has a possible upside of 56.85%. The high price target for TNDM is $60.00 and the low price target for TNDM is $5.50. There are currently 3 hold ratings and 9 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.752.752.892.86
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $44.6250$44.0417$30.50$9.9167
Price Target Upside: 56.85% upside21.43% upside15.11% downside22.71% downside

Tandem Diabetes Care (NASDAQ:TNDM) Consensus Price Target History

Price Target History for Tandem Diabetes Care (NASDAQ:TNDM)

Tandem Diabetes Care (NASDAQ:TNDM) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/9/2018OppenheimerSet Price TargetBuy$57.00MediumView Rating Details
11/3/2018Lake Street CapitalSet Price TargetBuy$60.00HighView Rating Details
11/2/2018Craig HallumSet Price TargetBuy$59.00HighView Rating Details
9/26/2018Dougherty & CoBoost Price TargetBuy$45.00 ➝ $56.00LowView Rating Details
9/26/2018Piper Jaffray CompaniesReiterated RatingAbove Average ➝ Overweight$32.00 ➝ $56.00MediumView Rating Details
9/14/2018Robert W. BairdDowngradeOutperform ➝ NeutralMediumView Rating Details
9/5/2018MEDBoost Price TargetOutperform$38.00 ➝ $54.00HighView Rating Details
8/30/2018Berenberg BankInitiated CoverageBuy ➝ Buy$50.00HighView Rating Details
8/24/2018Bank of AmericaUpgradeUnderperform ➝ Neutral$45.00HighView Rating Details
8/22/2018Stifel NicolausInitiated CoverageHold$25.00 ➝ $34.00HighView Rating Details
7/31/2018CowenReiterated RatingBuy$28.00HighView Rating Details
2/27/2018CitigroupInitiated CoverageOutperform$5.50LowView Rating Details
10/10/2017WedbushReiterated RatingOutperform$50.00 ➝ $17.00N/AView Rating Details
5/3/2017B. RileyReiterated RatingNeutral$15.00MediumView Rating Details
3/9/2017Northcoast ResearchReiterated RatingBuyN/AView Rating Details
(Data available from 11/20/2016 forward)
This page was last updated on 11/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel